Webinars
Bioassay Method Transfer Strategies to Reduce Variability
Learn how bioassay method transfer strategies support reliable assay performance and minimize variability in this insider session. Explore case studies that highlight the challenges and…
Comprehensive Analytical Strategies for ADC and mAb Control
Watch this insider session to gain practical insights into ADC and mAb characterization through real-world case studies using LC/MS, CE, SPR, and orthogonal methods. Learn…
Multidomain Biologics: Bioanalytical Strategies and Insights
Watch this on-demand webinar to learn how drug developers can address the unique bioanalytical challenges of multidomain biologics. Scientists from BioAgilytix share strategies for PK…
Translation of a Diagnostic Virus Neutralization Method to a Quantitative Relative Potency Assay for an Anti-Viral Antibody
Many anti-viral biotherapeutics operate through neutralization of the virus or kill infected cells and employ in vivo testing to measure potency, function and efficacy. In vivo assays are time-consuming…
Navigating IDE and IVDR Requirements in Drug Development
In this on-demand webinar, experts from BioAgilytix provide information on strategies to meet global regulatory expectations. Through real-world case studies and approaches, you’ll learn how…
Best Practices for the Development and Validation of qPCR and ddPCR Assays
The emergence and evolution of cell and gene therapy has led many bioanalytical laboratories to implement qPCR and/or ddPCR to support preclinical and clinical assays.
Flow Cytometry Tools to Support Cellular Therapies
In association with Bioanalysis Zone, BioAgilytix’s Chief Scientific Officer, provides an overview of the support for immuno-oncology programs by BioAgilytix, addressing pharmacokinetics, immunogenicity and biomarker…
Potency Assays For Gene & Cell Therapy Products
Hear from our team of experts that are helping our customers pursue the opportunities of this compelling therapeutic strategy by leveraging our deep NAb assay…
Assessing Cellular Immunogenicity via ELISpot
As therapeutic modalities have become more complex, such as cell and gene therapies, so too have the bioanalytical methods become more complex for characterizing these…
Full-Service Bioanalysis of an Immuno-Oncology Program
In association with Bioanalysis Zone, BioAgilytix’s Chief Scientific Officer provides an overview of their support for immuno-oncology programs, addressing pharmacokinetics, immunogenicity and biomarker assays.